These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34973207)

  • 1. Variability in repeat serum etonogestrel concentrations among contraceptive implant users during the steady-release pharmacokinetic period.
    Lazorwitz A; Sheeder J; Teal S
    Contraception; 2022 Apr; 108():65-68. PubMed ID: 34973207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Aquilante CL; Sheeder J; Guiahi M; Teal S
    Contraception; 2019 Jul; 100(1):37-41. PubMed ID: 30980827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study on the effect of isotretinoin on serum etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Seale R; Davis A; Guiahi M
    Contraception; 2020 Jul; 102(1):58-60. PubMed ID: 32325076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of plasma etonogestrel concentrations sampled from the contralateral-to-implant and ipsilateral-to-implant arms of contraceptive implant users.
    Gertz AM; Bishop IJ; Simon B; Lechiile K; Badubi O; Mussa A; Westhoff CL; Morroni C
    Contraception; 2020 Dec; 102(6):403-405. PubMed ID: 32858051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of rifampin on serum etonogestrel concentrations and biomarkers of ovulation among contraceptive implant users: A pharmacokinetic and pharmacodynamic study.
    Lazorwitz A; Sheeder J; Teal S
    Contraception; 2023 Jul; 123():110035. PubMed ID: 36997081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An exploratory study on the association of lifestyle factors with serum etonogestrel concentrations among contraceptive implant users.
    Lazorwitz A; Sheeder J; Teal S
    Eur J Contracept Reprod Health Care; 2021 Aug; 26(4):323-325. PubMed ID: 33596152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of etonogestrel released from the contraceptive implant Implanon.
    Wenzl R; van Beek A; Schnabel P; Huber J
    Contraception; 1998 Nov; 58(5):283-8. PubMed ID: 9883383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etonogestrel concentrations among contraceptive implant users in Botswana using and not using dolutegravir-based antiretroviral therapy.
    Bishop IJ; Gertz AM; Simon B; Tawe L; Lechiile K; Liu S; Teodoro N; Mussa A; Avalos A; Malima S; Maotwe T; Mokganya L; Westhoff CL; Morroni C
    Contraception; 2020 Sep; 102(3):174-179. PubMed ID: 32387328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Topiramate on Serum Etonogestrel Concentrations Among Contraceptive Implant Users.
    Lazorwitz A; Pena M; Sheeder J; Teal S
    Obstet Gynecol; 2022 Apr; 139(4):579-587. PubMed ID: 35594123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users.
    Lazorwitz A; Davis A; Swartz M; Guiahi M
    Contraception; 2017 Jun; 95(6):571-577. PubMed ID: 28288788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An exploratory study on the possible association of serum etonogestrel concentrations with mood concerns and symptoms among contraceptive implant users.
    Diamond B; Sheeder J; Lazorwitz A
    Contraception; 2024 Jan; 129():110298. PubMed ID: 37802462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant Users.
    Lazorwitz A; Aquilante CL; Oreschak K; Sheeder J; Guiahi M; Teal S
    Obstet Gynecol; 2019 Apr; 133(4):783-794. PubMed ID: 30870275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of the etonogestrel contraceptive implant in obese women.
    Mornar S; Chan LN; Mistretta S; Neustadt A; Martins S; Gilliam M
    Am J Obstet Gynecol; 2012 Aug; 207(2):110.e1-6. PubMed ID: 22717269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Etonogestrel Concentrations and Bleeding Patterns in Contraceptive Implant Users.
    Lazorwitz A; Aquilante CL; Dindinger E; Harrison M; Sheeder J; Teal S
    Obstet Gynecol; 2019 Oct; 134(4):807-813. PubMed ID: 31503152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of a novel, alternative subdermal scapular insertion site for the etonogestrel contraceptive implant.
    Clure C; Sheeder J; Lazorwitz A
    Contraception; 2024 Jul; 135():110442. PubMed ID: 38552822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of Implanon on lipid metabolism in comparison with Norplant.
    Suherman SK; Affandi B; Korver T
    Contraception; 1999 Nov; 60(5):281-7. PubMed ID: 10717780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
    Ali M; Akin A; Bahamondes L; Brache V; Habib N; Landoulsi S; Hubacher D;
    Hum Reprod; 2016 Nov; 31(11):2491-2498. PubMed ID: 27671673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
    Moeti DMP; Govender I; Bongongo T
    S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.